Cargando…

HMGN2, a new anti-tumor effector molecule of CD8(+) T cells

BACKGROUND: Cytolytic T lymphocytes (CTL) and natural killer (NK) cells have been implicated as important cells in antitumor responses. Our previous research has shown that high mobility group nucleosomal-binding domain 2 (HMGN2) could be released by IL-2 and PHA stimulated peripheral blood mononucl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Su, Lin, Hu, Ankang, Luo, Yang, Zhou, Wenjie, Zhang, Ping, Feng, Yun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4126642/ https://www.ncbi.nlm.nih.gov/pubmed/25060707 http://dx.doi.org/10.1186/1476-4598-13-178

Ejemplares similares

Nucleosome-binding protein HMGN2 exhibits antitumor activity in oral squamous cell carcinoma
por: HU, ANKANG, et al.
Publicado: (2014)

Human HMGN1 and HMGN2 are not required for transcription-coupled DNA repair
por: Apelt, Katja, et al.
Publicado: (2020)

Combined treatment with HMGN1 and anti-CD4 depleting antibody reverses T cell exhaustion and exerts robust anti-tumor effects in mice
por: Chen, Chang-Yu, et al.
Publicado: (2019)

Nucleosome structural changes induced by binding of non-histone chromosomal proteins HMGN1 and HMGN2()
por: Shimahara, Hideto, et al.
Publicado: (2013)

Biological Functions of HMGN Chromosomal Proteins
por: Nanduri, Ravikanth, et al.
Publicado: (2020)

Effects of HMGN variants on the cellular transcription profile
por: Rochman, Mark, et al.
Publicado: (2011)

Bortezomib enhances expression of effector molecules in anti-tumor CD8(+) T lymphocytes by promoting Notch-nuclear factor-κB crosstalk
por: Thounaojam, Menaka C., et al.
Publicado: (2015)

Effector CD4 and CD8 T Cells and Their Role in the Tumor Microenvironment
por: Hadrup, Sine, et al.
Publicado: (2012)

Lysine succinylation on non-histone chromosomal protein HMG-17 (HMGN2) regulates nucleosomal DNA accessibility by disrupting the HMGN2–nucleosome association
por: Jing, Yihang, et al.
Publicado: (2021)

Exogenous HMGN2 inhibits the migration and invasion of osteosarcoma cell lines
por: Xu, Enjie, et al.
Publicado: (2020)

CD8+CD39+ T Cells Mediate Anti-Tumor Cytotoxicity in Bladder Cancer
por: Zhu, Wenjie, et al.
Publicado: (2021)

Blockade of 6-phosphogluconate dehydrogenase generates CD8(+) effector T cells with enhanced anti-tumor function
por: Daneshmandi, Saeed, et al.
Publicado: (2021)

The Significance of Tumor Necrosis Factor Receptor Type II in CD8(+) Regulatory T Cells and CD8(+) Effector T Cells
por: Ye, Lin-Lin, et al.
Publicado: (2018)

Multimodal identification of rare potent effector CD8 T cells in solid tumors
por: Ray, Arja, et al.
Publicado: (2023)

Binding of HMGN proteins to cell specific enhancers stabilizes cell identity
por: He, Bing, et al.
Publicado: (2018)

Reduced CD5 on CD8(+) T Cells in Tumors but Not Lymphoid Organs Is Associated With Increased Activation and Effector Function
por: Alotaibi, Faizah, et al.
Publicado: (2021)

Tumor-specific CD4(+) T cells maintain effector and memory tumor-specific CD8(+) T cells
por: Church, Sarah E, et al.
Publicado: (2014)

Tim-3-Expressing CD4(+) and CD8(+) T Cells in Human Tuberculosis (TB) Exhibit Polarized Effector Memory Phenotypes and Stronger Anti-TB Effector Functions
por: Qiu, Yueqin, et al.
Publicado: (2012)

Apoptosis of tumor infiltrating effector TIM-3+CD8+ T cells in colon cancer
por: Kang, Chiao-Wen, et al.
Publicado: (2015)

Expression of HMGB1 and HMGN2 in gingival tissues, GCF and PICF of periodontitis patients and peri-implantitis
por: Xie, Ping, et al.
Publicado: (2011)

Functional genomics of HMGN3a and SMARCAL1 in early mammalian embryogenesis
por: Uzun, Alper, et al.
Publicado: (2009)

Effect of HMGN2 on proliferation and apoptosis of MCF-7 breast cancer cells
por: Fan, Bo, et al.
Publicado: (2019)

Multiple epigenetic factors co-localize with HMGN proteins in A-compartment chromatin
por: He, Bing, et al.
Publicado: (2022)

MicroRNA-140-5p regulates osteosarcoma chemoresistance by targeting HMGN5 and autophagy
por: Meng, Yichen, et al.
Publicado: (2017)

Noninvasive interrogation of CD8(+) T cell effector function for monitoring early tumor responses to immunotherapy
por: Zhou, Haoyi, et al.
Publicado: (2022)

Metabolomics Reveals a Role for the Chromatin-Binding Protein HMGN5 in Glutathione Metabolism
por: Ciappio, Eric D., et al.
Publicado: (2014)

Functional compensation among HMGN variants modulates the DNase I hypersensitive sites at enhancers
por: Deng, Tao, et al.
Publicado: (2015)

Chromatin De-Compaction By The Nucleosomal Binding Protein HMGN5 Impairs Nuclear Sturdiness
por: Furusawa, Takashi, et al.
Publicado: (2015)

HMGN1 and 2 remodel core and linker histone tail domains within chromatin
por: Murphy, Kevin J., et al.
Publicado: (2017)

The Role of Anti-Viral Effector Molecules in Mollusc Hemolymph
por: Watson, Angus, et al.
Publicado: (2022)

CD4(+) cytotoxic T cells: an emerging effector arm of anti-tumor immunity
por: Jeong, Seongmin, et al.
Publicado: (2023)

Differential Expression of CD96 Surface Molecule Represents CD8(+) T Cells with Dissimilar Effector Function during HIV-1 Infection
por: Eriksson, Emily M., et al.
Publicado: (2012)

Deletion of PTPN22 improves effector and memory CD8(+) T cell responses to tumors
por: Brownlie, Rebecca J., et al.
Publicado: (2019)

Suppressive effects of the obese tumor microenvironment on CD8 T cell infiltration and effector function
por: Dyck, Lydia, et al.
Publicado: (2022)

Regulation of CD4(+) and CD8(+) Effector Responses by Sprouty-1
por: Collins, Sam, et al.
Publicado: (2012)

Rapid Effector Function in CD8(+) Memory T Cells
por: Lalvani, Ajit, et al.
Publicado: (1997)

Notch controls effector CD8(+) T cell differentiation
por: Duval, Frédéric, et al.
Publicado: (2015)

NKG2D defines tumor‐reacting effector CD8(+) T cells within tumor microenvironment
por: Mojic, Marija, et al.
Publicado: (2021)

Tumor Rejection Induced by CD70-mediated Quantitative and Qualitative Effects on Effector CD8(+) T Cell Formation
por: Arens, Ramon, et al.
Publicado: (2004)

Functional Change of Effector Tumor-Infiltrating CCR5(+)CD38(+)HLA-DR(+)CD8(+) T Cells in Glioma Microenvironment
por: Chen, Pin-Yuan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_04b6p6fjt9gi67gjsoah4n2c4p